These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19743909)

  • 21. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
    Vallely A; Fitzgerald L; Fiya V; Aeno H; Kelly A; Sauk J; Kupul M; Neo J; Millan J; Siba P; Kaldor JM
    BMC Res Notes; 2012 Nov; 5():613. PubMed ID: 23116431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with sexually transmitted infection underreporting among female sex workers in China.
    Hong Y; Fang X; Zhou Y; Zhao R; Li X
    J Womens Health (Larchmt); 2011 Jan; 20(1):129-36. PubMed ID: 21194309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study.
    Rosen RK; Morrow KM; Carballo-Diéguez A; Mantell JE; Hoffman S; Gai F; Maslankowski L; El-Sadr WM; Mayer KH
    J Womens Health (Larchmt); 2008 Apr; 17(3):383-92. PubMed ID: 18328009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muslim women's reflections on the acceptability of vaginal microbicidal products to prevent HIV infection.
    Hoel N; Shaikh S; Kagee A
    Ethn Health; 2011 Apr; 16(2):89-106. PubMed ID: 21328113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Women's interest in vaginal microbicides.
    Darroch JE; Frost JJ
    Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels.
    van den Berg JJ; Rosen RK; Bregman DE; Thompson LA; Jensen KM; Kiser PF; Katz DF; Buckheit K; Buckheit RW; Morrow KM
    AIDS Behav; 2014 May; 18(5):862-70. PubMed ID: 24248674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Willingness to use microbicides is affected by the importance of product characteristics, use parameters, and protective properties.
    Morrow KM; Fava JL; Rosen RK; Vargas S; Barroso C; Christensen AL; Woodsong C; Severy L
    J Acquir Immune Defic Syndr; 2007 May; 45(1):93-101. PubMed ID: 17325607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Willingness to use microbicides varies by race/ethnicity, experience with prevention products, and partner type.
    Morrow KM; Fava JL; Rosen RK; Christensen AL; Vargas S; Barroso C
    Health Psychol; 2007 Nov; 26(6):777-86. PubMed ID: 18020851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.
    Olsen ML; Cwiak CA; Koudelka C; Jensen JT
    Contraception; 2007 Oct; 76(4):314-8. PubMed ID: 17900444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city.
    Peitzmeier SM; Tomko C; Wingo E; Sawyer A; Sherman SG; Glass N; Beyrer C; Decker MR
    AIDS Care; 2017 Nov; 29(11):1453-1457. PubMed ID: 28271718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of partnership dynamics in determining the acceptability of condoms and microbicides.
    Montgomery CM; Lees S; Stadler J; Morar NS; Ssali A; Mwanza B; Mntambo M; Phillip J; Watts C; Pool R
    AIDS Care; 2008 Jul; 20(6):733-40. PubMed ID: 18576176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
    Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D
    Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
    [No Abstract]   [Full Text] [Related]  

  • 33. Preferences and practices related to vaginal lubrication: implications for microbicide acceptability and clinical testing.
    Braunstein S; van de Wijgert J
    J Womens Health (Larchmt); 2005 Jun; 14(5):424-33. PubMed ID: 15989415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of adherent use of diaphragms and microbicide gel in a four-arm, randomized pilot study among female sex workers in Madagascar.
    Turner AN; Van Damme K; Jamieson DJ; Khan MR; Pettifor AE; Swezey TA; Bell AJ; Newman DR; Penman-Aguilar A; Raharinivo MS; Randrianasolo B; Ramiandrisoa FN; Behets FM;
    Sex Transm Dis; 2009 Apr; 36(4):249-57. PubMed ID: 19265745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perceptions of acceptability and utility of microbicides in Ghana, West Africa: a qualitative, exploratory study.
    Tanner AE
    SAHARA J; 2008 Apr; 5(1):11-8. PubMed ID: 18496615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A profile of HIV risk factors in the context of sex work environments among migrant female sex workers in Beijing, China.
    Yi H; Mantell JE; Wu R; Lu Z; Zeng J; Wan Y
    Psychol Health Med; 2010 Mar; 15(2):172-87. PubMed ID: 20391235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acceptability of a microbicide among women and their partners in a 4-country phase I trial.
    Bentley ME; Fullem AM; Tolley EE; Kelly CW; Jogelkar N; Srirak N; Mwafulirwa L; Khumalo-Sakutukwa G; Celentano DD
    Am J Public Health; 2004 Jul; 94(7):1159-64. PubMed ID: 15226137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparing for microbicide trials in Rwanda: focus group discussions with Rwandan women and men.
    Veldhuijzen N; Nyinawabega J; Umulisa M; Kankindi B; Geubbels E; Basinga P; Vyankandondera J; Van De Wijgert J
    Cult Health Sex; 2006; 8(5):395-406. PubMed ID: 16923644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal microbicides for HIV/STI prevention in Zimbabwe: what key informants say.
    Moon MW; Khumalo-Sakutukwa GN; Heiman JE; Mbizvo MT; Padian NS
    J Transcult Nurs; 2002 Jan; 13(1):19-23. PubMed ID: 11776011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health practices and vaginal microbicide acceptability among urban black women.
    Reiff M; Wade C; Chao MT; Kronenberg F; Cushman LF
    J Womens Health (Larchmt); 2008 Oct; 17(8):1345-51. PubMed ID: 18788991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.